Cargando…

Medical Marijuana and Opioids (MEMO) Study: protocol of a longitudinal cohort study to examine if medical cannabis reduces opioid use among adults with chronic pain

INTRODUCTION: In the USA, opioid analgesic use and overdoses have increased dramatically. One rapidly expanding strategy to manage chronic pain in the context of this epidemic is medical cannabis. Cannabis has analgesic effects, but it also has potential adverse effects. Further, its impact on opioi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cunningham, Chinazo O, Starrels, Joanna L, Zhang, Chenshu, Bachhuber, Marcus A, Sohler, Nancy L, Levin, Frances R, Minami, Haruka, Slawek, Deepika E, Arnsten, Julia H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Research Methods
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778768/ https://www.ncbi.nlm.nih.gov/pubmed/33376181 http://dx.doi.org/10.1136/bmjopen-2020-043400

Ejemplares similares

Willingness to Participate in Longitudinal Research Among People with Chronic Pain Who Take Medical Cannabis: A Cross-Sectional Survey
por: Bachhuber, Marcus A., et al.
Publicado: (2018)

“It doesn’t make any sense to even try”: the disruptive impact of COVID-19’s first wave on people with chronic pain using medical cannabis in New York
por: Zolotov, Yuval, et al.
Publicado: (2023)

Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder
por: Fox, Aaron D, et al.
Publicado: (2015)

Association of US Medical Marijuana Laws With Nonmedical Prescription Opioid Use and Prescription Opioid Use Disorder
por: Segura, Luis E., et al.
Publicado: (2019)

Availability of medical cannabis services by racial, social, and geographic characteristics of neighborhoods in New York: a cross-sectional study
por: Cunningham, Chinazo O., et al.
Publicado: (2022)

Reducing the default dispense quantity for new opioid analgesic prescriptions: study protocol for a cluster randomised controlled trial
por: Bachhuber, Marcus A, et al.
Publicado: (2018)

Changes in Outpatient Opioid Prescribing During the COVID-19 Pandemic: An Interrupted Time Series Analysis
por: Rikin, Sharon, et al.
Publicado: (2022)

State marijuana laws and opioid overdose mortality
por: Chihuri, Stanford, et al.
Publicado: (2019)

Analysis of State Cannabis Laws and Dispensary Staff Recommendations to Adults Purchasing Medical Cannabis
por: Merlin, Jessica S., et al.
Publicado: (2021)

Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Osteoarthritis
por: Renslo, Bryan, et al.
Publicado: (2022)

Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs
por: Scott, Travis M., et al.
Publicado: (2021)

Cannabis and the Opioid Crisis
por: Piomelli, Daniele, et al.
Publicado: (2018)

Effect of Changing Electronic Health Record Opioid Analgesic Dispense Quantity Defaults on the Quantity Prescribed: A Cluster Randomized Clinical Trial
por: Bachhuber, Marcus A., et al.
Publicado: (2021)

Associations of Parental Marijuana Use With Offspring Marijuana, Tobacco, and Alcohol Use and Opioid Misuse
por: Madras, Bertha K., et al.
Publicado: (2019)

Ohio physician attitudes toward medical Cannabis and Ohio’s medical marijuana program
por: Lombardi, Emilia, et al.
Publicado: (2020)

Prescription Opioid Distribution after the Legalization of Recreational Marijuana in Colorado
por: Kropp Lopez, Amalie K., et al.
Publicado: (2020)

Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
por: Nunes, Edward V., et al.
Publicado: (2021)

Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: a preliminary study
por: Scott, Travis M., et al.
Publicado: (2017)

Medical Marijuana (Cannabis sativa L.) and COVID-19: A note
por: Joob, Beuy, et al.
Publicado: (2022)

Substitution of marijuana for opioids in a national survey of US adults
por: Ishida, Julie H., et al.
Publicado: (2019)

Cannabis dispensary staff approaches to counseling on potential contraindications to cannabis use: insights from a national self-report survey
por: Slawek, Deepika E., et al.
Publicado: (2023)

Accuracy of Patient Opioid Use Reporting at the Time of Medical Cannabis License Renewal
por: Vigil, Jacob M., et al.
Publicado: (2018)

Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report
por: Reiman, Amanda, et al.
Publicado: (2017)

Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Chronic Back Pain
por: Greis, Ari, et al.
Publicado: (2022)

A Survey on the Effect That Medical Cannabis Has on Prescription Opioid Medication Usage for the Treatment of Chronic Pain at Three Medical Cannabis Practice Sites
por: Takakuwa, Kevin M, et al.
Publicado: (2020)

Cannabis use among opioid-dependent individuals on opioid substitution therapy
por: Balhara, Yatan Pal Singh, et al.
Publicado: (2014)

Association between medical cannabis laws and opioid overdose mortality has reversed over time
por: Shover, Chelsea L., et al.
Publicado: (2019)

Caring for Patients With Opioid Use Disorder: What Clinicians Should Know About Comorbid Medical Conditions
por: Slawek, Deepika E., et al.
Publicado: (2018)

Establishing Credibility for Medical Marijuana: The Proposed Prometheus Dispensary Registry for Botanical Cannabis
por: Langley, Paul C
Publicado: (2019)

Medical marijuana
por: Melvin, Darrel, et al.
Publicado: (2015)

Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication
por: Shover, Chelsea L., et al.
Publicado: (2020)

Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States
por: Wadsworth, Elle, et al.
Publicado: (2022)

Medical Cannabis for the Primary Care Physician
por: Slawek, Deepika, et al.
Publicado: (2019)

Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
por: Lee, Cerina, et al.
Publicado: (2021)

The holistic effects of medical cannabis compared to opioids on pain experience in Finnish patients with chronic pain
por: Jylkkä, Jussi, et al.
Publicado: (2023)

Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry
por: Brown, Joshua D., et al.
Publicado: (2020)

Association Between Spine Surgery and Availability of Opioid Medication
por: Warner, Nafisseh S., et al.
Publicado: (2020)

OLDER ADULTS' PERCEPTIONS OF CANNABIS AND OPIOIDS USE
por: Bobitt, Julie
Publicado: (2022)

“A place at the table:” a qualitative analysis of community board members’ experiences with academic HIV/AIDS research
por: Safo, Stella, et al.
Publicado: (2016)

Non-Medical Prescription Opioid Use and Prescription Opioid Use Disorder: A Review
por: Tetrault, Jeanette M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d1bjsrq56shqodqaol112ddi82